Orchid Chemicals And Pharma

• Orchid Chemicals Gets USFDA Nod for Two Generic Drugs

  Drug firm Orchid Chemicals & Pharmaceuticals has received the US health regulator's nod for generic Rivastigmine capsules and Felodipine extended release tablets aimed at treating mild to moderate dementia and hypertension, respectively.

• Orchid Pharma's debt restructuring proposal approved by CDR cell

  The Corporate Debt Restructuring Empowered Group (CDR EG) has approved Orchid Chemicals and Pharmaceuticals' debt restructuring proposal, the pharma company said on Friday.

• US regulator raises concerns at Tamil Nadu Hospira facility

  The FDA said it found that surfaces in the facility were not always sanitised prior to use and that sterile drug products were not protected from contamination.

• Orchid Chemicals in talks with lenders to restructure over Rs 1,100 crore loan

  Chennai-based pharma company Orchid Chemicals and Pharmaceuticals is in talks with various lenders to restructure over Rs 1,100 crore loan, which largely comprises working capital loans.

• What is Rakesh Jhunjhunwala buying and selling

  Billionaire investors Rakesh Jhunjhunwala has been restructuring his portfolio amid the broad selloff,.